PIONEER Trial:Hemodynamic Support With ECMO and IABP in Elective Complex High-risk PCI
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 306 participants.
Also called NCT04045873
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 306 participants
- Sponsor
- Registry
-
NCT04045873
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT04045873. Randomized; no masking; primary purpose treatment. Start 2019-12 (anticipated); primary completion 2021-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PIONEER Trial:Hemodynamic Support With ECMO and IABP in Elective Complex High-risk PCI
- Condition
- Coronary Artery Disease
- Condition
- Heart Failure
- Intervention (Device)
- extracorporeal membrane oxygenation
- Lead sponsor
- Xijing Hospital
- Collaborator
- The First Affiliated Hospital of Zhengzhou University
- Collaborator
- Bethune International Peace Hospital
- Collaborator
- Beijing Anzhen Hospital
- Collaborator
- The Second Affiliated Hospital of Harbin Medical University
- Collaborator
- The General Hospital of Northern Theater Command
Record details
- Record id
cardio:ct-nct04045873- Content hash
8ffa5c580d83ab5fad31979b5b697b93e36a00cf54b8743d25866192af51dbd9